SAN DIEGO (October 9, 2024) — Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced the successful initial $6
SAN DIEGO (September 5, 2024) — Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, commends the U.S. Food & Drug Administration’s
SAN DIEGO (July 25, 2024) — Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, is launching a new line of
SAN DIEGO, March 4, 2024 – Amprion is pleased to announce its presence at the AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and related
SAN DIEGO, February 9, 2024 – Amprion is pleased to be affiliated with a new scientific paper published in Alzheimer’s & Dementia, entitled “Investigating alpha-synuclein co-pathology
San Diego Business Journal, February 9, 2023 Parkinson’s disease, Alzheimer’s disease, Lewy Body Dementia – neurological conditions that affect people as they age are often
SAN DIEGO, August 15, 2023 – Amprion has been contracted by the National Institutes of Health (NIH) Intramural Research Program’s Center for Alzheimer’s and Related Dementias (CARD)
SAN DIEGO, August 15, 2023 – Amprion, a global leader in neurodegenerative disease diagnostics, continues to fortify its Intellectual Property surrounding the company’s proprietary methodology
SAN DIEGO, April 21, 2023 – Amprion is pleased to announce that it will attend the American Academy of Neurology (AAN) Annual Meeting in Boston April 22-27 to
SAN DIEGO, March 27, 2023 – Amprion is pleased to announce its attendance at the AD/PD™ 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and
A pioneer in the science of detecting misfolded proteins, Amprion advances the diagnosis of brain disorders. Our SAAmplify™-ɑSYN Test aids physicians in diagnosing Parkinson’s, Lewy body dementia, and Alzheimer’s with Lewy body variant. We plan to launch more biomarker tests in the future.
Our flagship α-synuclein SAA, SYNTap®, is getting a makeover.
Effective September 9, 2024, SYNTap will be
And stay tuned for the SAAmplify family of panels, coming soon!
